Our Advertisers Represent Some Of The Most Unique Products & Services On Earth!


Hepatitis D Outbreak Kills 35 - 
108 Hospitalized In India So Far

From Patricia Doyle, PhD
2-24-9
 
Hello Jeff - I am not sure what we have here. It appears that there may be a mutant HBV virus in India. HDV also know as Hepatitis Delta virus - and is only present in patients who are infected with Hepatitis B Virus, is being blamed for deaths and illness in India.
 
As you will note below, even the experts are not sure what is going on. Hopefully, more information will be forthcoming. If there is a novel HBV agent, it can be very serious and could certainly spread throughout Asia and the world.
 
Sadly, it appears the outbreak may be due to medical provider negligence.  
 
I will keep you updated.
 
Patty
 
 
[1] Date: Mon 23 Feb 2009 From: Jose Manuel Echevarria 
 
A comment --------- As far as I know, no mutant hepatitis B virus (HBV) infection  producing 30 percent mortality among infected persons has ever been  reported to date anywhere. If a virus was involved, just  superinfection of HBV carriers by hepatitis D virus (HDV), also known  as hepatitis delta agent, would be responsible for an outbreak of  acute liver disease with such a high mortality rate, otherwise  additional symptoms may suggest yellow fever or other serious  diseases that may include hepatic involvement as a complication. This  possibility has been, however, apparently ruled-out by laboratory  studies. Since such mutant HBV would represent a novel and most  relevant viral agent, detailed information concerning laboratory  evidences that support such an explanation for the outbreak should be  given by regional or federal health authorities as soon as possible.
 
-- Jose M Echevarria, MSc PhD Virologist Head, Service of Diagnostic Microbiology National Centre of Microbiology Instituto de Salud Carlos III Majadahonda, Madrid Spain
 
[The most recently available statement from India, posted below,  gives the number of hospitalised cases in this outbreak as 108 and  the number of deaths as 35. There is no additional information on the  outcome of laboratory investigations. - Mod.CP]
 
******
 
[2] Date Sun 22 Feb 2009 Source: Prensa Latina online (in Spanish, machine trans., edited]
 
http://www.prensalatina.com.mx/Article.asp?ID=%7B26B
BA932-2470-42DE-8FCC-EE6D64A0CA51%7D&language=ES>
 
 
One of the 7 doctors arrested in the Indian state of Gujarat for  negligence in a fatal outbreak of hepatitis B, was prosecuted for  manslaughter, reports today's [22 Feb 2009] Times of India newspaper.
 
The researchers found that most patients who contracted the disease  and eventually died were treated by him. The outbreak was due to the  use of poorly sterilized syringes, experts noted. As of Saturday  night [21 Feb 2009], the death toll in Modasa had reached 35, while  108 others are hospitalized in that locality of Gujarat, said the  newspaper.
 
A doctor who runs a clinic opposite the Modasa public health centre  is the 1st doctor accused of murder, while 6 others face various  charges under the Medical Negligence Act. Health officials revealed  that the focus of this outbreak of liver disease has spread to  Malpur, Bayad, and Idar Taluka, all in Sabarkantha district, where  Modasa is also located.
 
-- Communicated by: HealthMap Alerts via ProMED-mail <mailto:promed@promedmail.org>promed@promedmail.org
 
[A map showing the location of Sabarkantha district in Gujarat state  can be accessed at  http://en.wikipedia.org/wiki/File:Map_GujDist_North.png. The HealthMap/ProMED-mail interactive map of India showing the  location of Gujarat state can be accessed at 
http://healthmap.org/promed/en?g=1262958&v=23.467,73.3,5
. - Mod.CP]
 
 
ORIGINAL REPORT
 
Date: Fri 13 Feb 2009 Source: Thaindian News [edited]
http://www.thaindian.com/newsportal/health/eleven-die-of-hepatitis-d-in-gujarat-district_100154892.html
 
 
A total of 11 deaths due to hepatitis-D were reported so far in  Modasa taluka of Gujarat's Sabarkantha district in the last 5 days,  health officials here said. Officials said 21 patients are admitted  to various hospitals in the area so far, and 5 were rushed to the  civil hospital in Ahmedabad Friday [13 Feb 2009].
 
"We have asked for a central team from the National Institute of  Communicable Diseases (NICD) and the Director General of Health  Services (DGHS), and the team is arriving shortly," said Chief  District Health Officer (CDHO) H.F. Patel.
 
A 3-member team from the B.J. Medical College, Ahmedabad, led by  Nayan Qadri, has already arrived in Modasa Thursday [12 Feb 2009].  "At present, 5 doctors and 27 paramedics are in the area," Patel said.
 
The hepatitis-D virus (also called delta virus) is a small circular  RNA virus and affects humans only in the presence of hepatitis-B  infection. It is transmitted by blood and blood products. The risk  factors for infection are similar to those for hepatitis-B virus  infection. The hepatitis-D virus most often infects intravenous drug  users, Patel said. "We have published 25 000 pamphlets, and we are  circulating them as part of our awareness campaign," he said.
 
-- Communicated by: ProMED-mail Rapporteur Brent Barrett
 
[In ProMED archive no. 20030712.1718, Mod.CP wrote the following  about Hepatitis D virus infections: Because hepatitis delta virus  (HDV) is dependent on hepatitis B virus (HBV) for replication,  HBV/HDV co-infection can be prevented with either pre- or  post-exposure prophylaxis for HBV. HDV infection can be acquired  either as a co-infection with HBV or as a superinfection of persons  with chronic HBV infection. Persons with HBV/HDV co-infection may  have more severe acute disease and a higher risk of fulminant  hepatitis (2-20 percent) compared with those infected with HBV alone;  however, chronic HBV infection appears to occur less frequently in  individuals with HBV/HDV co-infection. Chronic HBV carriers who  acquire HDV superinfection usually develop chronic HDV infection. In  long-term studies of chronic HBV carriers with HDV superinfection,  70-80 percent have developed evidence of chronic liver diseases with  cirrhosis compared with 15-30 percent of patients with chronic HBV  infection alone. Thus, prevention of HDV superinfection depends  primarily on education to reduce risk behaviors. In some Latin  American countries in the Amazon River Basin, periodic epidemics of  HDV infection have occurred among chronic HBV carriers in relatively  isolated regions. Disease related to HDV infection in these outbreaks  has been very severe, with rapid progression to fulminant hepatitis  and case-fatality rates of 10-20 percent. The cause of the atypical  course of HDV infection in these populations is unknown.
 
The modes of HDV transmission are similar to those for HBV, with  percutaneous exposures the most efficient. Sexual transmission of HDV  is less efficient than for HBV. Perinatal HDV transmission is rare.  The serologic course of HDV infection varies depending on whether the  virus is acquired as a co-infection with HBV or as a superinfection  of a person with chronic HBV infection. In most persons with HBV/HDV  co-infection, both IgM antibody to HDV (anti-HDV) and IgG anti-HDV  are detectable during the course of infection. However, in about 15  percent of patients, the only evidence of HDV infection may be the  detection of either IgM anti-HDV alone during the early acute period  of illness or IgG anti-HDV alone during convalescence. Anti-HDV  generally declines to sub-detectable levels after the infection  resolves, and there is no serologic marker that persists to indicate  that the patient was ever infected with HDV. Hepatitis Delta antigen  (HDAg) can be detected in serum in only about 25 percent of patients  with HBV-HDV co-infection. When HDAg is detectable, it generally  disappears as HBsAg disappears, and most patients do not develop  chronic infection. - Mod.CP]
 
[The basis on which the HDV diagnosis was made in this Indian  outbreak was not indicated in the above report. ProMED requests  information about any laboratory tests done in these cases and  further information about the outbreak as it becomes available.
 
The administrative headquarters of the Sabarkantha district is  Himmatnagar, 80 km (50 miles) from Ahmedabad. The District has a  population of over 2 million in its 7390 sq km (2853 sq mi) area.
 
A map showing the location of Sabarkantha district in Gujarat state  can be accessed at
 
 
http://en.wikipedia.org/wiki/File:Map_GujDist_North.png
 
 
A HealthMap/ProMED-mail interactive map of India showing the location  of Gujarat state can be accessed at
http://healthmap.org/promed/en?v=22.9,79.6,5 - Mod.TY
 
 
Patricia A. Doyle DVM, PhD Bus Admin, Tropical Agricultural Economics
Univ of West Indies Please visit my "Emerging Diseases" message board at:
http://www.emergingdisease.org/phpbb/index.php Also my new website:
http://drpdoyle.tripod.com/ Zhan le Devlesa tai sastimasa
Go with God and in Good Health 
 
 
Disclaimer
 
Donate to Rense.com
Support Free And Honest
Journalism At Rense.com
Subscribe To RenseRadio!
Enormous Online Archives,
MP3s, Streaming Audio Files, 
Highest Quality Live Programs


MainPage
http://www.rense.com


This Site Served by TheHostPros